Nippon India Pharma Fund
Holdings
38
Concentrated
Top 10 weight
58%
Concentration
Strategy
Active
Portfolio style
Equity
98%
Asset allocation
Portfolio
3Sectors6Large positions72.5%Top: Pharmaceuticals & Biotechnology2.4%Cash
Market-cap allocation
Large cap40%
Mid cap27%
Small cap31%
Asset allocation
Equity98%
Top holdings
Sun Pharmaceutical Industries LimitedEQUITY12.8%
Lupin LimitedEQUITY7.5%
Dr. Reddy's Laboratories LimitedEQUITY6.7%
Cipla LimitedEQUITY6.2%
Divi's Laboratories LimitedEQUITY5.5%
Apollo Hospitals Enterprise LimitedEQUITY5.3%
Mankind Pharma LimitedEQUITY4.0%
Sai Life Sciences LimitedEQUITY3.5%
Ajanta Pharma LimitedEQUITY3.5%
Max Healthcare Institute LimitedEQUITY3.3%
Sign in for free to unlock all 38 holdings →Portfolio insights
Portfolio read
- 98% equity.
- Large-cap exposure is 40%.
- Largest equity sector is Pharmaceuticals & Biotechnology at 72.5%.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 72%.
Generated from current fund metrics. Educational research only.
Peer comparison
Other funds in Thematic Fund.
Explore comparable funds →Sector exposure
Showing top sectors from the current portfolio.
Healthcare Services22.0%
Retailing3.2%